glp 1 agonist trials Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Emerging Trends in the Development

Once a formula is prescribed, a registered nurse places a small IV catheter most commonly in the forearm or hand and the infusion begins

This leads to interrupted nerve cell formation (neurogenesis), loss of neural connections, and accumulation of a neurotoxic protein called hyperphosphorylated tau in the hippocampus

Individual vials

Biol Reprod

Per FDA guidance, GLP-1-based medications are generally approved for adults with a BMI over 30, or over 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol

Seth Kipnis, medical director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center, noted that there have been "rare and unusual side effects" from this class of medications, but he believes the vision changes seem to be more related to the rapid blood sugar changes caused by the medications than to the medications themselves